-
Report: Biosimilars could save $20 billion per year
While the Food and Drug Administration released draft guidance on regulations for biosimilars in February 2012, the final regulations have yet to appear. But already, everyone from analysts to trade groups to drug makers is preparing for a time when knock-off versions of biotech drugs will become available.
A new report sheds light on some of the opportunities and challenges that exist in follow-on biologics, arguing that their opportunity to generate value depends on factors like the speed of development, clarity of regulation, ease of access and the roles of all stakeholders.
-
Rite Aid comps decrease 3.6% as same-store prescription count increases 0.3%
CAMP HILL, Pa. — Rite Aid's same-store sales for February 2013 decreased by 3.6% over the previous year, including a 1.3% decrease in front-end same-store sales and a 4.7% decrease in pharmacy same-store sales, the retail pharmacy chain said Thursday.
Front-end comps attributable to flu-related OTC products were flat, while pharmacy comps included a negative effect of 695 basis points from new generic introductions. Same-store prescription count increased 0.3%, including a 0.1% decrease attributable to flu shots and prescription flu drugs.